tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu is a glucagon-like peptide-1 analog.
CAT No: 10-101-287
CAS No:1118767-16-0
Synonyms/Alias:1118767-16-0;(S)-22-(Tert-butoxycarbonyl)-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontane-1,41-dioic acid;(S)-22-(tert-Butoxycarbonyl)-43,43-dimethyl-10,19,24,41-tetraoxo-3,6,12,15,42-pentaoxa-9,18,23-triazatetratetracontanoic acid;tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu;DVN2QPW6DR;SCHEMBL1676919;MFCD34186911;TBUO-STE-GLU(AEEA-AEEA-OH)OTBU;BS-48103;FT181995;E79903;(2-{2-[2-(2-{2-[(4S)-5-(tert-butoxy)-4-[18-(tert-butoxy)-18-oxooctadecanamido]-5-oxopentanamido]ethoxy}ethoxy)acetamido]ethoxy}ethoxy)acetic acid;2-[2-[2-[[2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[18-[(2-methylpropan-2-yl)oxy]-18-oxooctadecanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]acetyl]amino]ethoxy]ethoxy]acetic acid;3,6,12,15-TETRAOXA-9,18,23-TRIAZAHENTETRACONTANEDIOIC ACID, 22-((1,1-DIMETHYLETHOXY)CARBONYL)-10,19,24-TRIOXO-, 41-(1,1-DIMETHYLETHYL) ESTER, (22S)-;41-(1,1-DIMETHYLETHYL) (22S)-22-((1,1-DIMETHYLETHOXY)CARBONYL)-10,19,24-TRIOXO-3,6,12,15-TETRAOXA-9,18,23-TRIAZAHENTETRACONTANEDIOATE;
Chemical Name:18-[[5-[2-[2-[2-[2-[2-(Carboxymethoxy)ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]amino]-18-oxooctadecanoic acid
tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu is a synthetic peptide derivative featuring a stearoylated glutamic acid core, extended by two units of aminoethoxyethoxyacetic acid (AEEA) and protected with tert-butyl (tBu) groups at both termini. This unique structural configuration imparts amphiphilic properties, enhanced solubility, and increased flexibility, making the molecule particularly valuable in advanced biochemical research and peptide engineering. The inclusion of AEEA spacers provides additional hydrophilicity and conformational adaptability, which are advantageous for a range of bioanalytical and functional studies. Researchers utilize such modified peptides for their customizable physicochemical characteristics and their capacity to facilitate targeted interactions in complex biological environments.
Peptide Synthesis and Conjugation: The compound's protected termini and AEEA linker segments make it an excellent intermediate for solid-phase peptide synthesis (SPPS) and solution-phase coupling strategies. The tBu protecting groups safeguard reactive sites during sequential assembly or conjugation reactions, allowing for precise elongation or functionalization without undesired side reactions. Its design is particularly suited for constructing branched or multifunctional peptides, as the AEEA spacers provide spatial separation that reduces steric hindrance during coupling with other biomolecules, dyes, or affinity tags.
Biomaterials and Surface Engineering: The amphiphilic nature of this peptide derivative enables its integration into self-assembled monolayers, hydrogels, or nanoparticle coatings. The stearoyl moiety facilitates anchoring to hydrophobic surfaces or lipid bilayers, while the hydrophilic AEEA spacers and glutamic acid backbone enhance aqueous compatibility and functional group presentation. Researchers leverage these properties to develop biofunctional surfaces for biosensors, cell culture substrates, or targeted delivery systems, where controlled orientation and spatial arrangement of functional groups are critical for performance.
Molecular Spacer and Linker Studies: The dual AEEA units in the structure serve as flexible, hydrophilic linkers, offering valuable insight into the effects of spacer length and composition on peptide conformation and bioactivity. Investigators employ such constructs to systematically evaluate how linker elements influence molecular recognition, binding kinetics, and signal transduction in peptide-based assays or receptor-ligand studies. The ability to modulate the distance between functional domains is essential for optimizing activity in engineered peptides and protein mimetics.
Analytical Method Development: The presence of defined hydrophobic and hydrophilic domains, along with robust protecting groups, makes this compound an effective calibration or reference standard for analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS). It provides a model system for method development, enabling the evaluation of chromatographic retention, detection sensitivity, and fragmentation patterns for amphiphilic or branched peptides. Such standards are instrumental in validating analytical protocols for complex peptide mixtures or modified biomolecules.
Drug Delivery Research: The stearoylated and AEEA-extended glutamic acid scaffold has significant utility in the design and evaluation of peptide-based delivery vehicles. Its amphiphilic profile supports the formation of micelles, vesicles, or conjugates capable of encapsulating hydrophobic or hydrophilic payloads. In preclinical and formulation research, scientists use such constructs to study the stability, assembly dynamics, and release profiles of peptide-carrier systems, informing the rational design of advanced delivery platforms for bioactive molecules in non-clinical applications.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.